Fluorescence In Situ Hybridization (FISH) and Cytogenetic (CG) Karyotype Studies in Myelodysplastic Syndrome (MDS): One or Both?

被引：0
|
作者：
Durnick, D. K. [1 ]
Ketterling, R. P. [1 ]
Hoyer, J. D. [1 ]
Steensma, D. P. [1 ]
Van Dyke, D. L. [1 ]
Hodnefield, J. M. [1 ]
Knudson, R. A. [1 ]
Hanson, C. A. [1 ]
机构：
[1] Mayo Clin, Rochester, MN USA
来源：
LABORATORY INVESTIGATION | 2010年 / 90卷
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
1318
引用
收藏
页码：294A / 294A
页数：1
相关论文
共 50 条
  • [1] Fluorescence In Situ Hybridization (FISH) and Cytogenetic (CG) Karyotype Studies in Myelodysplastic Syndrome (MDS): One or Both?
    Durnick, D. K.
    Kenerling, R. P.
    Hoyer, J. D.
    Steensma, D. P.
    Van Dyke, D. L.
    Hodnefield, J. M.
    Knudson, R. A.
    Hanson, C. A.
    MODERN PATHOLOGY, 2010, 23 : 294A - 294A
  • [2] Combination of Fluorescence in situ Hybridization (FISH) and Cytogenetic Techniques Optimizes the Diagnostic Process of Patients with Myelodysplastic Syndrome (MDS)
    Trakhtenbrot, L.
    Merkel, D.
    Novikov, I.
    Nagler, A.
    Amariglio, N.
    CYTOGENETIC AND GENOME RESEARCH, 2012, 136 (04) : 335 - 335
  • [3] Combination Of Fluorescence In SITU Hybridization (FISH) and Cytogenetic Techniques Optimize The Diagnostic Process Of Patients With Myelodysplastic Syndrome (MDS)
    Merkel, Drorit
    Navikov, Ilia
    Avigdor, Abraham
    Amariglio, Ninette
    Nagler, Arnon
    Trakhtenbrot, Luba
    BLOOD, 2013, 122 (21)
  • [4] Conventional Cytogenetic Analysis and FISH in Myelodysplastic Syndrome (MDS): Are Both Necessary?
    Wiktor, A. E.
    Van Dyke, D. L.
    Ketterling, R. P.
    Hanson, C. A.
    CYTOGENETIC AND GENOME RESEARCH, 2012, 136 (04) : 335 - 336
  • [5] Conventional cytogenetic (CC), fluorescence in situ hybridization (FISH) and comparative genomic hybridization (CGH) analysis in patients with myelodysplastic syndromes (MDS)
    Skonieczka, Olga Haus
    Duszenko, Ewa
    Mucha, Barbara
    Babicz, Mariusz
    Wyrowinska, Elzbieta
    Swistek, Wojciech
    CHROMOSOME RESEARCH, 2007, 15 : 203 - 204
  • [6] Cytogenetic aberrations in myelodysplastic syndrome detected by comparative genomic hybridization and fluorescence in situ hybridization
    Wilkens, L
    Burkhardt, D
    Tchinda, J
    Büsche, G
    Werner, M
    Nolte, M
    Ganser, A
    Georgii, A
    DIAGNOSTIC MOLECULAR PATHOLOGY, 1999, 8 (01) : 47 - 53
  • [7] Fluorescence in Situ Hybridization (FISH) Frequently Upstages Risk Estimates for MDS Patients with Normal Metaphase Karyotype
    Komrokji, Rami S.
    Ramadan, Hanadi
    Al Ali, Najla
    Sallman, David A.
    Padron, Eric
    Sweet, Kendra
    Lancet, Jeffrey E.
    List, Alan F.
    BLOOD, 2017, 130
  • [8] Update of cytogenetic risk factors in MDS (Part II): a strategy to incorporate fluorescence in situ hybridization (FISH) and "FISH on a Chip" (aCGH) results in future clinical trials for the myelodysplastic syndromes (MDS)
    Slovak, M. L.
    Dewald, G.
    LEUKEMIA RESEARCH, 2009, 33 : S10 - S10
  • [9] Fluorescence in Situ Hybridization (FISH) Utility for Risk Score Assessment in Patients With MDS With Normal Metaphase Karyotype
    Schwabkey, Zaker, I
    Al Ali, Najla
    Chan, Onyee
    Sallman, David A.
    Padron, Eric
    Kuykendall, Andrew T.
    Talati, Chetasi
    Sweet, Kendra
    Lancet, Jeffrey E.
    Komrokji, Rami S.
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2021, 21 (01): : E52 - E56
  • [10] Comparison of Fluorescence In-Situ Hybridization (FISH) and Conventional Cytogenetics (CC) in Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS)
    Aggarwal, G.
    Manaloor, E.
    Ramalingam, P.
    MODERN PATHOLOGY, 2010, 23 : 283A - 283A
12345